Senior insider sale
Principal Accounting Officer at ACADIA PHARMACEUTICALS INC — senior position signals high conviction
$208.2K
9.71K shares
What this filing means
KIHARA JAMES plans to sell 9.71K shares of ACADIA PHARMACEUTICALS INC valued at approximately $208.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/26/2026ACC: 0001950047-26-005016
Officer· Principal Accounting Officer
Since Jun 2020
9.71K
Shares to sell
$208.2K
Approx. market value
5.40K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months3
Performance Shares
Not Applicable
11/18/2024
3.86KEmployee Stock Purchase Plan
Cash
5/13/2022
1.05KEmployee Stock Purchase Plan
Cash
11/13/2020
491.00Total acquired5.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/18/2024 | Performance Shares Not Applicable | 3.86K | — |
5/13/2022 | Employee Stock Purchase Plan Cash | 1.05K | — |
11/13/2020 | Employee Stock Purchase Plan Cash | 491.00 | — |
| Total | 5.40K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.33K
Market value
$29.0K
5/4/2026
—Completed
Units to sell
1.03K
Market value
$22.9K
4/7/2026
—Completed
Units to sell
1.11K
Market value
$24.0K
3/26/2026
—Completed
Units to sell
833.00
Market value
$17.9K
3/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.40K
Market value
$114.4K
5/26/2026
Total
Units
9.71K
Value
$208.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 1.33K | $29.0K | — | Completed |
4/7/2026 | 1.03K | $22.9K | — | Completed |
3/26/2026 | 1.11K | $24.0K | — | Completed |
3/25/2026 | 833.00 | $17.9K | — | Completed |
| Planned — Approximate Date | ||||
5/26/2026 | 5.40K | $114.4K | NASDAQ | Planned |
| Total | 9.71K | $208.2K | ||